Molecular Partners Ag (MOLN) Operating Expenses (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Operating Expenses for 7 consecutive years, with -$17.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 17.79% year-over-year to -$17.2 million in Q2 2026; TTM through Jun 2026 was -$42.8 million, a 174.22% decrease from a year earlier, with the FY2025 full-year figure at -$48.5 million, down 187.77% from the prior year.
• Operating Expenses was -$17.2 million for Q2 2026 at Molecular Partners Ag, roughly flat from -$17.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $114.1 million in Q4 2024 and troughed at -$21.3 million in Q1 2024.
• A 5-year average of -$7.5 million and a median of -$18.0 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses sank 189.53% in 2023 and soared 672.68% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at -$18.3 million in 2022, then decreased by 8.78% to -$19.9 million in 2023, then jumped by 672.68% to $114.1 million in 2024, then sank by 94.19% to $6.6 million in 2025, then slumped by 359.22% to -$17.2 million in 2026.
• The last three Operating Expenses figures came in at -$17.2 million (Q2 2026), -$17.2 million (Q1 2026), and $6.6 million (Q4 2025), per Business Quant data.